Cresset Asset Management, LLC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 247 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cresset Asset Management, LLC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$207,334
-8.8%
45,568
+41.1%
0.00%
Q2 2023$227,336
+20.0%
32,292
+4.2%
0.00%
-100.0%
Q1 2023$189,410
-4.4%
31,0000.0%0.00%
+33.3%
Q4 2022$198,090
-54.0%
31,000
-31.1%
0.00%
-40.0%
Q3 2022$431,000
+62.6%
45,000
+87.3%
0.01%
+66.7%
Q2 2022$265,000
-44.7%
24,032
-16.5%
0.00%
-40.0%
Q1 2022$479,000
+29.8%
28,794
+48.5%
0.01%
+25.0%
Q4 2021$369,000
-20.8%
19,387
+2.6%
0.00%
-33.3%
Q3 2021$466,000
-22.3%
18,892
-18.1%
0.01%
-25.0%
Q2 2021$600,000
+80.2%
23,066
+118.9%
0.01%
+60.0%
Q1 2021$333,00010,5350.01%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
MHR Fund Management 19,997,103$90,986,81911.15%
MPM BioImpact LLC 3,287,397$14,957,6563.99%
Perceptive Advisors 11,962,938$54,431,3671.82%
CM Management, LLC 200,000$910,0000.97%
Velan Capital Investment Management LP 250,000$1,137,5000.92%
Opaleye Management Inc. 610,000$2,775,5000.90%
Boxer Capital, LLC 3,705,133$16,858,3550.90%
SECTORAL ASSET MANAGEMENT INC 985,000$4,481,7500.87%
Parametrica Management Ltd 95,400$434,0700.73%
683 Capital Management, LLC 2,050,000$9,327,5010.72%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders